HomeTOP STORIESKalVista, Ionis/Sobi among latest to win EU nod for rare disease drugs KalVista, Ionis/Sobi among latest to win EU nod for rare disease drugs By rogerjudd September 19, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleVaxart withdraws reverse stock split proposalNext articleMorgan Stanley to liquidate Calvert US Select Equity ETF next month latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
